Following up on their decision to integrate R&D into a single organization — joining discovery and development under one chief — Germany’s Bayer is scrutinizing its research group with an eye to streamlining its operations.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,